- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/34 - Nitrogen atom attached in position 6, e.g. adenine
Patent holdings for IPC class C07D 473/34
Total number of patents in this class: 1073
10-year publication summary
|
115
|
91
|
102
|
86
|
75
|
63
|
44
|
56
|
48
|
27
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ono Pharmaceutical Co., Ltd. | 434 |
26 |
| Gilead Sciences, Inc. | 2037 |
25 |
| Novartis AG | 10850 |
23 |
| Intellikine LLC | 42 |
19 |
| K36 Therapeutics, Inc. | 22 |
17 |
| AstraZeneca AB | 2908 |
16 |
| Dana-Farber Cancer Institute, Inc. | 2564 |
16 |
| Amgen Inc. | 4044 |
15 |
| Rhizen Pharmaceuticals AG | 56 |
15 |
| Epizyme, Inc. | 370 |
14 |
| Infinity Pharmaceuticals, Inc. | 99 |
14 |
| Sloan-Kettering Institute for Cancer Research | 520 |
13 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2853 |
13 |
| The Regents of the University of California | 19929 |
12 |
| Incyte Corporation | 1024 |
12 |
| Memorial Sloan-Kettering Cancer Center | 1930 |
12 |
| Univerzita Palackeho V Olomouci | 135 |
12 |
| F. Hoffmann-La Roche AG | 7921 |
11 |
| Gilead Calistoga LLC | 35 |
11 |
| The Scripps Research Institute | 1351 |
11 |
| Other owners | 766 |